SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-081250
Filing Date
2011-03-29
Accepted
2011-03-29 16:02:44
Documents
43
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1120586
2 SPECIMEN COMMON STOCK CERTIFICATE OF THE REGISTRANT dex42.htm EX-4.2 16825
3 WARRANT dex1016.htm EX-10.16 50873
4 MASTER SERVICES AGREEMENT - AAI DEVELOPMENTAL SERVICES INC. dex1049.htm EX-10.49 71477
5 FIRST AMENDMENT TO MASTER SERVICES AGREEMENT - AAIPHARMA INC. dex1050.htm EX-10.50 10210
6 SECOND AMENDMENT TO MASTER SERVICES AGREEMENT - AAIPHARMA INC. dex1051.htm EX-10.51 11584
7 THIRD AMENDMENT TO MASTER SERVICES AGREEMENT - AAIPHARMA SERVICES CORP dex1052.htm EX-10.52 11530
8 MASTER SERVICES AGREEMENT - ALBANY MOLECULAR RESEARCH, INC. dex1053.htm EX-10.53 102520
9 MASTER SERVICES AGREEMENT - ICON CLINICAL RESEARCH LIMITED dex1054.htm EX-10.54 278724
10 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1859
11 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 6481
12 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 6687
13 CERTIFICATION OF CEO & CFO PURSUANT TO 13A-14(B) OR 15D-14(B) dex321.htm EX-32.1 5835
14 GRAPHIC g168745ex10_16pg9.jpg GRAPHIC 5889
15 GRAPHIC g168745ex10_49pg9a.jpg GRAPHIC 2972
16 GRAPHIC g168745ex10_49pg9b.jpg GRAPHIC 9655
17 GRAPHIC g168745ex10_49pg9c.jpg GRAPHIC 4422
18 GRAPHIC g168745ex10_50a.jpg GRAPHIC 1343
19 GRAPHIC g168745ex10_50b.jpg GRAPHIC 8661
20 GRAPHIC g168745ex10_50c.jpg GRAPHIC 3908
21 GRAPHIC g168745ex10_50d.jpg GRAPHIC 3708
22 GRAPHIC g168745ex10_51pg2a.jpg GRAPHIC 1067
23 GRAPHIC g168745ex10_51pg2b.jpg GRAPHIC 4360
24 GRAPHIC g168745ex10_51pg2c.jpg GRAPHIC 4568
25 GRAPHIC g168745ex10_51pg2d.jpg GRAPHIC 3263
26 GRAPHIC g168745ex10_52pg2a.jpg GRAPHIC 2058
27 GRAPHIC g168745ex10_52pg2b.jpg GRAPHIC 6987
28 GRAPHIC g168745ex10_52pg2c.jpg GRAPHIC 1904
29 GRAPHIC g168745ex10_52pg2d.jpg GRAPHIC 6392
30 GRAPHIC g168745ex10_53pg15a.jpg GRAPHIC 5178
31 GRAPHIC g168745ex10_53pg15b.jpg GRAPHIC 2866
32 GRAPHIC g168745ex10_53pg15c.jpg GRAPHIC 1834
33 GRAPHIC g168745ex10_53pg15d.jpg GRAPHIC 4619
34 GRAPHIC g168745ex10_54pg19a.jpg GRAPHIC 3674
35 GRAPHIC g168745ex10_54pg19b.jpg GRAPHIC 5900
36 GRAPHIC g168745ex10_54pg19c.jpg GRAPHIC 6424
37 GRAPHIC g168745ex10_54pg19d.jpg GRAPHIC 4821
38 GRAPHIC g168745ex10_54pg19e.jpg GRAPHIC 4886
39 GRAPHIC g168745ex10_54pg1to23.jpg GRAPHIC 4013
40 GRAPHIC g168745ex10_54pg23.jpg GRAPHIC 1097
41 GRAPHIC g168745ex10_54pg24to27.jpg GRAPHIC 4633
42 GRAPHIC g168745g90b80.jpg GRAPHIC 298678
43 GRAPHIC g168745g92b14.jpg GRAPHIC 39413
  Complete submission text file 0001193125-11-081250.txt   2333814
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 11718782
SIC: 2834 Pharmaceutical Preparations